Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02795819
Title Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Virginia Commonwealth University
Indications

renal cell carcinoma

sarcoma

Therapies

AR-42 + Pazopanib

Age Groups: adult
Covered Countries USA


No variant requirements are available.